FIELD: medicine, pharmaceutics.
SUBSTANCE: there are presented a method of treating post-traumatic stress disorder, a method of improving a resistance to any symptom of post-traumatic stress disorder, a diagnostic technique for post-traumatic stress disorder, all using (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)amide 4-hydroxy-4-methylpiperidine-1-carboxylic acid, a based pharmaceutical composition for treating a patient diagnosed with post-traumatic stress disorder.
EFFECT: what is shown is eliminating stress-induced anhedonia and relieving APEC-induced decreased motion activity by (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)amide 4-hydroxy-4-methylpiperidine-1-carboxylic acid.
21 cl, 12 ex
